[2] |
Siegel R,Ma J,Zou Z,et al.Cancer statistics[J].CA,2014, 64(1):9-29.
|
[4] |
Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747-752.
|
[1] |
Redig AJ,McAllister SS.Breast cancer as a systemic disease:a view of metastasis[J].J Intern Med,2013,274(2):113-126.
|
[3] |
Wang CH,Li JZ,Zhang W.Breast cancer molecular subtypes of Uygur and Han in Xinjiang of China[J].Int J Clin Exp Med,2014,7(4):1116-1121.
|
[5] |
Hochest B,Diehl L.Antigen shedding into the circulation contributes to tumor immune escape[J].Oncoimmunology,2012,1(9):1620-1622.
|
[6] |
秦颖,张同先,张巍,等.青年乳腺癌临床病理特点分子分型及预后分析[J].中国肿瘤临床,2014,41(4):231-236.
|
[7] |
Witte E,Witte K,Warszawska K,et al.Interleukin -22:a cytokine produced by T,NK and NKT cell subsets,with importance in the innate immune defense and tissue protection[J].Cytokine Growth Factor Rev,2010,21(5):365-379.
|
[8] |
张铁英,康丽花,刘远航,等.不同分子亚型乳腺癌T淋巴细胞和NK细胞检测的临床意义[J].中国妇幼保健,2015,30(21):3594-3595.
|
[9] |
Rad FR,Ajdary S,Omranipour R,et al.Comparative analysis of CD4+and CD8+T cells in tumor tissues,lymph nodes and the peripheral blood from patients with breast cancer[J]. Iran Biomed J,2015,19(1):35.
|
[10] |
冀为,周岩,牛瑞芳.外周血T淋巴细胞亚群与不同分子分型乳腺癌患者无病生存的相关性研究[J].中国肿瘤临床,2014,41(21):1363-1367.
|
[11] |
Tabariès S,Ouellet V,Hsu BE,et al.Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases[J].Breast Cancer Res,2015,17(1):1-18.
|
[12] |
孙林,温江涛,刘海红.乳腺癌患者外周血T淋巴细胞及NK细胞的检测及其临床意义[J].现代肿瘤医学,2006,14(9):1069-1071.
|
[13] |
林志明,刘慧,高全立,等.乳腺癌患者外周血中调节性T细胞的表达及意义[J].现代预防医学,2011,38(12):2258-2260.
|
[14] |
李永峰,吴云飞,张慧.淋巴结转移比率在预测淋巴结转移乳腺癌患者预后中的价值[J].中国普外基础与临床杂志,2011,18(7):750-754.
|
[15] |
朱赤红,许沈华,凌雨田.乳腺癌外周血淋巴细胞亚群检测及其预后意义[J].中国卫生检验杂志,2013,23(14):2957-2960.
|
[16] |
韦录,吴向华,刘金录,等.乳腺癌复发转移的相关分子生物学指标临床意义的研究[J].广西医科大学学报,2012,29(2):237-239.
|